Adverse Events of Everolimus in Patients with Tuberous Sclerosis Complex Treated for Renal Angiomyolipoma/Subependymal Giant Cell Astrocytoma

Background: Although regarded as a potentially efficient approach to address tuberous sclerosis complex (TSC)-associated complications, the adverse event profile of everolimus has not yet been fully elucidated. The present study aimed to clarify the adverse event spectrum in patients with TSC who ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Gau, Shuo-Yan, Chen, Sung-Lang, Chang, Cheng-Siu, Tsao, Teng-Fu, Tsai, Jeng-Dau
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542024/
https://www.ncbi.nlm.nih.gov/pubmed/37786437
http://dx.doi.org/10.7150/ijms.88022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542024/
https://www.ncbi.nlm.nih.gov/pubmed/37786437
http://dx.doi.org/10.7150/ijms.88022

Ejemplares similares